Randomized Controlled Trial Protocol on Buttonhole Cannulation: A Technique to Reduce Arteriovenous Fistula Access Complications  by Chow, Josephine et al.
Hong Kong J Nephrol • October 2010 • Vol 12 • No 2 105
Nursing Section
INTRODUCTION
People with end-stage renal disease (ESRD) require a 
reliable access to their circulatory system to receive life-
sustaining hemodialysis (HD). The ideal access would 
be long-lasting, free of complications, and permit ade-
quate flow rates to deliver effective treatments. The clos-
est form of access to the “ideal” is the native arteriovenous 
fistula (AVF). The 2008 Australian and New Zealand 
Data Registry [1] reported that 76% of prevalent HD pa-
tients possess an AVF for their dialysis access. However, 
the native AVF is subject to complications due to throm-
bosis and almost always as a direct effect from venous 
outflow stenosis which contribute to endothelial and 
smooth muscle hyperplasia associated with injury to the 
venous wall [2]. Recent thought suggests that flow 
turbulence may contribute to endothelial injury whereby 
the platelet plug formed from cannulation of the access 
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initiates a chemical response enhancing platelet-derived 
growth factor to act on downstream vessel walls [3]. 
Thrombosis in the AVF can be catastrophic as connecting 
vascular networks fill with clotting blood, rendering the 
vessels useless [4]. In the United States, access compli-
cation is the major cause of hospital admissions among 
the ESRD population, affecting not only their morbidity 
but contributing significantly to the financial burden on 
the health service [3].
The longevity of AVFs is not only reliant on vessel 
quality and creative surgical skill but also on access can-
nulation. There is no set standard of techniques for access 
cannulation, although most HD centers rotate their can-
nulation sites using the rationale that time will allow 
healing and prevent complications such as hematoma, 
infection, aneurysm and adjacent stenosis [5].
Constant site cannulation came about by chance 
and was first described in 1977 by Twardowski et al [6]. 
A patient receiving HD in Poland had insufficient area 
on his access to rotate his cannulation sites, necessitating 
constant site cannulation. It was observed that this pa-
tient had less pain, less difficulty and quicker and greater 
ease with cannulation of his access.
Kronung [7] renamed this method the “buttonhole” 
technique after he examined the effects on AVFs from 
different cannulation techniques. He found that cannula-
tion around a confined area produced aneurysm and 
adjacent stenosis of the AVF. Rotation of the cannulation 
sites in the fashion of a “ladder” produced small dilata-
tions (but no aneurysms) over the length of the AVF. 
Kronung found that no dilatation or stenosis of the AVF 
with the buttonhole technique was observed and the tech-
nique also allowed a quicker, more accurate cannulation, 
producing less hematoma and less pain [7].
Guidelines published by the Vascular Access Society 
[8] for the routine management of AVFs and grafts sup-
ported Kronung’s 1984 report and added less bleeding 
and no significant increase in infection to the benefits of 
the buttonhole technique. For the buttonhole technique 
to be successful, it requires the access to be cannulated 
in the same direction, the same site and at the same angle 
until scar tissue develops around the cannula forming a 
track or tunnel. This may take 8–12 weeks [2]. Once the 
track is developed, blunt needles are used to avoid dam-
aging the tunnel during cannulation. The effects of using 
this method have only been reported in AVFs and saphe-
nous vein grafts (SVGs) [8].
A prospective observational study by Verhallen et al 
[9] compared buttonhole with rope ladder cannulation 
techniques among the self-cannulating home HD popu-
lation over an 18-month period. They found that nursing 
staff considered the buttonhole cannulation technique 
an overall success in almost 80% of cases. There was a 
significant improvement in cannulation ease and the num-
ber of infiltrations also decreased significantly. There 
was no development of aneurysm during the study period 
and existing aneurysm appeared to reduce in size. Pain 
during cannulation was less with buttonhole cannulation 
but not significantly. However, three episodes of local 
skin infection were reported.
Infection rates with buttonhole cannulation may be 
increased. Doss et al [10] felt that infection rates with 
buttonhole cannulation may have been underestimated. 
Suggestions that the ease of cannulation may have led 
to lapses in proper skin preparation procedures and re-
ported incidents of patients incorrectly removing the scab 
once again led to a review of the skin preparation pro-
cedure and resulted in the practice of disinfecting the 
skin before and after removal of the scab.
The literature has reported the advantages of button-
hole cannulation. However, many of the studies reported 
have been observational and, to date, there has not been 
a randomized controlled trial comparing buttonhole can-
nulation with other methods of cannulation. Therefore, 
a 6-month multicenter, prospective, open-label random-
ized controlled trial has been planned to determine if the 
use of the buttonhole technique in new and established 
AVF and SVG access may reduce complications and pro-
long the access life compared to current unit practice.
MATERIALS AND METHODS
Ethics approval was obtained from the local institutional 
ethics committee in all participating centers prior to 
study initiation and patient enrolment. The study will 
be performed in accordance with the 2000 Edinburgh, 
Scotland, Revision of the Declaration of Helsinki, the 
National Health and Medical Research Committee 
(NHMRC) Statement on Human Experimentation, Joint 
NHMRC/AVCC Statement and Guidelines on Research 
Practice, applicable ICH guidelines.
Patient population
The study population will include adult participants with 
ESRD who are receiving HD and who are able to provide 
informed consent. The inclusion criteria for the study 
participants include:
• online access flow measurement—thermodilution 
method of ≥ 500 mL/minute;
• patent AVF or SVG with sufficient area for buttonhole 
formation away from aneurysmal formations.
Patients with evidence of infection, swelling or bruis-
ing of the AVF or SVG will be excluded from the study. 
Patients with a stenosis as indicated by high venous pres-
sure or ultrasound will also be excluded from the study.
The study will include both incident and prevalent 
patients receiving maintenance HD treatment. Prevalent 
patients may possess recall bias from a previous adverse 
experience; however, these patients will be included in 
the study. Patients will be selected from the HD units and 
the Home Training Program within a tertiary teaching 
Hong Kong J Nephrol • October 2010 • Vol 12 • No 2 107
 Trial protocol on buttonhole cannulation
area health service. The multicenter nature of the study 
together with the inclusion criteria used will greatly 
enhance the generalizability of the study.
Study design
The study will follow a prospective, open-label random-
ized controlled trial design. Patients will be randomized 
in equal proportions to one of two groups (Figure). The 
randomization process will involve an independent person 
choosing a sealed envelope containing a randomization 
group allocating the participant to either the intervention 
(buttonhole) group or the control (usual practice) group.
Experimental intervention
Patients in the experimental intervention arm will have 
the establishment of their buttonhole site attended by 
designated clinicians. The same clinician will cannulate 
the same site using sharp needles for 2–4 weeks to allow 
for tunnel development. Following tunnel development, 
blunt needles will be used for cannulation.
Control intervention
Patients in the control intervention arm will continue 
with the usual practice of rope ladder rotation technique.
Blinding
Blinding of the investigators and patients is not possible 
because of the completely different characteristics of 
the buttonhole and rope ladder cannulation techniques.
Outcome measures
The outcome measures include:
• quality of life using KDQOL;
• pain assessment of cannulation using a visual analog 
scale;
• lignocaine use;
• hematological and biochemical analyses;
• fistula observations (patency, thrombosis, trauma, 
inflammation, bruising, swelling);
• adequacy of treatment using Kt/V measure;
• cannulation proficiency;
• arterial and venous pressures;
• complications.
Clinical assessment of outcome
Demographic data will be obtained from medical re-
cords and the ANZDATA Registry database. Parameters 
to be collected include age, sex, predisposing renal dis-
ease, comorbidities and date of first HD.
Inclusion:
• Incident and prevalent patients receiving maintenance hemodialysis treatment
• Online access flow measurement—thermodilution method (Fresenius BTM) of ≥ 500 mL/min
• Patent AVF or SVG with sufficient area for buttonhole formation away from aneurismal formations
n = 70
Patient population
• Quality of life using KDQOL
• Pain assessment of cannulation using visual analog scale
• Lignocaine use
• Dialysis adequacy using Kt/V value
• Monthly hematology and biochemistry comparisons
• Fistula observations
• Cannulation proficiency
• Hemostasis time
• Complications
Outcome measures:
Follow-up at 6 months
• Establishment of buttonhole site attended
 by designated clinicians
• Same clinician to cannulate the same site
 using sharp needles for 2–4 weeks and,
 following tunnel development, changed
 to blunt needles
n = 35
Intervention group
• Continue with departmental practice of
 rope leader cannulation of fistula
n = 35
Control group
Randomization
Figure. Schema for the buttonhole study.
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Clinical data will be collected at dialysis appointments 
from medical records, dialysis notes and flow charts. 
The subjects will be asked about the level of pain they 
feel during cannulation and the corresponding level of 
pain in the Wong-Baker scale will be documented. The 
number of attempts at cannulation and subject-reported 
time to hemostatics will also be collected.
Adverse events including infections, hematoma, 
fistula complications and hospitalizations will be re-
corded at each study visit.
The experience of pain will be assessed using the 
Wong-Baker Pain Rating Scale, a visual analog scale 
from 0 (no pain) to 5 (worst pain). The Wong-Baker pain 
scale is a well validated tool used in the pediatric popula-
tion to measure pain intensity [11]. This visual pain scale 
is easy to understand and easy to score. The tool was cho-
sen for this study as for many potential subjects, English 
is their second language and the visual faces make it 
easier to measure pain rating.
Cannulation proficiency will be assessed by docu-
menting the number of attempts required to insert a 
functioning arterial and venous needle. Variability will 
exist with cannulation as more than one staff member 
will be performing cannulation. During buttonhole 
development, only senior nursing staff will be desig-
nated to perform this task. Following the change to blunt 
needles, all staff will perform cannulation. Cannulation 
proficiency will also be assessed using the Kt/V value 
where a level of 1.2 is considered the minimum target 
of adequacy [12].
Overview
Subjects will be evaluated for entry from the current 
HD population and as potential new subjects commence 
HD. Following informed consent and randomization, 
subjects will have study visits scheduled at regular time 
intervals according to the Time and Events Schedule 
(Table). The study protocol will end after the 6-month 
follow-up period, following early voluntary withdrawal, 
following receipt of a transplant or the death of the 
subject.
Screening visit
Subjects will be evaluated for entry criteria during a 
screening visit. This visit will be conducted prior to the 
HD session or during a routine clinic visit. The study will 
be explained to subjects and/or their family members and 
informed consent will be sought in writing. The following 
procedures will be initiated at the screening visit:
• subject demographics;
• predisposing renal disease and comorbidities;
• fistula observations.
Baseline visit
The following baseline procedures will be attended 
following informed consent:
• KDQOL survey;
• fistula observations;
• hematological and biochemical analyses;
• cannulation proficiency, needle size and site;
• visual analog scale pain survey;
• arterial and venous pressures;
• lignocaine use;
• blood flow rates;
• adequacy of treatment using Kt/V measure;
• hemostasis data;
• complications.
Intervention phase
Establishment of the buttonhole track will be attended by 
designated clinicians. Documentation of all study proce-
dures, data collection and adverse events will be recorded 
in the case record forms during the study visits. A number 
of data collection and procedures will be attended at each 
study visit according to the study Time and Events Sched-
ule (Table). In conjunction with this data collection and 
these procedures, hematological and biochemical analyses 
are attended at monthly intervals during the study visits.
Table. Study time and events schedule
Study activities Screening,  Study intervention Wk 1 Wk 2 Wk 3 Wk 4 Monthly End
 recruitment baseline
Informed consent X       
Subject demographics X       
Medications  X     X 
Predisposing renal disease & comorbidities X       
Fistula observations X X X X X X X X
Cannulation parameters  X X X X X X X
Hematological & biochemical parameters  X     X 
KDQOL survey  X      X
Treatment parameters  X X X X X X X
Pain survey using visual analog scale  X X X X X X X
Bleeding assessment  X X X X X X X
Complications  X X X X X X 
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Completion of study
The final visit will be attended after a 6-month follow-up 
period, which includes a number of data collection and 
procedures (Table). Study participants will be withdrawn 
from the study following transplant, death or upon their 
personal request.
Data collection, procedures, complications and safety 
evaluations will not be monitored or recorded by des-
ignated study personnel after completion of the study 
protocol.
Sample size calculations
A prospective power calculation has been done. If the ex-
pected incidence of moderate to severe pain on cannula-
tion is to be 80% in the control group, and 40% in the 
buttonhole group, the study would need 30 subjects in 
each group to achieve a power of 0.9 with a type 1 error 
rate of 0.5. This number has been rounded up to 35 in 
each group to allow for drop outs (a total of 70 subjects).
Statistical analyses
Frequency distributions and contingency tables will be 
used to examine the differences between buttonhole and 
control groups at baseline, weeks 1–4, and monthly until 
the end of the study at month 6.
Continuous data will be analyzed using t tests and 
categorical data will be analyzed using contingency 
tables and χ2 test.
DISCUSSION
This multicenter Australian study has been designed 
to provide evidence to help nephrology clinicians and 
their patients better determine whether or not the but-
tonhole cannulation technique in new and established 
AVF and SVG access will reduce complications and 
prolong access life compared to current practice.
One of the significant barriers to this study has been 
the belief of nursing staff that the buttonhole technique 
is superior to usual practice as it has been used for many 
years in dialysis units within Australia and around the 
globe. However, the majority of the dialysis units fa-
vored this study on the basis that this study is:
(1) supported by randomized controlled trial evidence;
(2) recommended as the standard of care by numbers 
of home dialysis training units; and
(3) likely to be associated with a lower propensity to pro-
mote easy cannulation by staff and patients.
The inclusion criteria has been kept as broad as pos-
sible to maximize the generalizability of the study re-
sults to the general HD population. Moreover, the study 
sample size has been carefully and prospectively calcu-
lated using a conservative estimate of pain during can-
nulation rate and a generous estimate of study drop out 
rate to minimize the risk of a type 2 statistical error.
A key early issue that has been identified is the need 
to provide education to patients and clinical staff to 
allow them to assess the correct timing for changing 
from sharp to blunt needles following tunnel develop-
ment. This difficulty will be overcome by training and 
maintaining a small number of experienced dialysis 
nurses to cannulate the patients during tunnel develop-
ment in the initial period of the study.
A limitation of the study is the 6-month follow-up 
period in both the control and intervention groups. 
Vascular access complications may occur late in the 
course of the access. Planning is in progress for a long-
term longitudinal follow-up study.
It is hoped that the results of this study will be avail-
able in late 2010. Demonstration of a significant im-
provement in cannulation of AVF-related complications 
will provide clinicians with an important new strategy 
in managing dialysis access.
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